INM Stock Overview
Focuses on the development of medical simulators based on Virtual Realty technology for use in education in esthetic and clinical dermatology. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
InventionMed S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.16 |
| 52 Week High | zł0.32 |
| 52 Week Low | zł0.16 |
| Beta | 0.29 |
| 11 Month Change | -16.87% |
| 3 Month Change | -18.51% |
| 1 Year Change | -21.24% |
| 33 Year Change | -28.43% |
| 5 Year Change | -47.33% |
| Change since IPO | -89.03% |
Recent News & Updates
Recent updates
Shareholder Returns
| INM | PL Medical Equipment | PL Market | |
|---|---|---|---|
| 7D | -13.4% | -6.1% | -3.1% |
| 1Y | -21.2% | -12.8% | -1.7% |
Return vs Industry: INM underperformed the Polish Medical Equipment industry which returned -12.8% over the past year.
Return vs Market: INM underperformed the Polish Market which returned -1.7% over the past year.
Price Volatility
| INM volatility | |
|---|---|
| INM Average Weekly Movement | 5.1% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in PL Market | 8.6% |
| 10% least volatile stocks in PL Market | 3.0% |
Stable Share Price: INM has not had significant price volatility in the past 3 months compared to the Polish market.
Volatility Over Time: INM's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 4 | Tomasz Kierul | inventionmed.com |
InventionMed S.A. focuses on the development of medical simulators based on Virtual Realty technology for use in education in esthetic and clinical dermatology. Its flagship project is TutorDerm, a simulator and an application that lets users perform actions necessary to treat specific dermatological diseases. The company also offers double immersion, and Virtual Syringe, a training equipment for specialists in clinical and aesthetic dermatology.
InventionMed S.A. Fundamentals Summary
| INM fundamental statistics | |
|---|---|
| Market cap | zł35.08m |
| Earnings (TTM) | -zł4.21m |
| Revenue (TTM) | zł46.86k |
712.3x
P/S Ratio-7.9x
P/E RatioIs INM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| INM income statement (TTM) | |
|---|---|
| Revenue | zł46.86k |
| Cost of Revenue | zł109.09k |
| Gross Profit | -zł62.23k |
| Other Expenses | zł4.15m |
| Earnings | -zł4.21m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.021 |
| Gross Margin | -132.81% |
| Net Profit Margin | -8,979.20% |
| Debt/Equity Ratio | 0% |
How did INM perform over the long term?
See historical performance and comparison